全文获取类型
收费全文 | 1852篇 |
免费 | 119篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 93篇 |
妇产科学 | 17篇 |
基础医学 | 212篇 |
口腔科学 | 212篇 |
临床医学 | 169篇 |
内科学 | 281篇 |
皮肤病学 | 31篇 |
神经病学 | 106篇 |
特种医学 | 198篇 |
外科学 | 225篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 161篇 |
眼科学 | 13篇 |
药学 | 113篇 |
中国医学 | 2篇 |
肿瘤学 | 103篇 |
出版年
2021年 | 13篇 |
2019年 | 14篇 |
2018年 | 26篇 |
2017年 | 20篇 |
2016年 | 26篇 |
2015年 | 34篇 |
2014年 | 34篇 |
2013年 | 48篇 |
2012年 | 51篇 |
2011年 | 60篇 |
2010年 | 39篇 |
2009年 | 37篇 |
2008年 | 58篇 |
2007年 | 52篇 |
2006年 | 50篇 |
2005年 | 74篇 |
2004年 | 74篇 |
2003年 | 71篇 |
2002年 | 68篇 |
2001年 | 58篇 |
2000年 | 65篇 |
1999年 | 58篇 |
1998年 | 43篇 |
1997年 | 35篇 |
1996年 | 40篇 |
1995年 | 37篇 |
1994年 | 36篇 |
1993年 | 33篇 |
1992年 | 35篇 |
1991年 | 40篇 |
1990年 | 45篇 |
1989年 | 46篇 |
1988年 | 52篇 |
1987年 | 42篇 |
1986年 | 29篇 |
1985年 | 42篇 |
1984年 | 34篇 |
1983年 | 33篇 |
1982年 | 34篇 |
1981年 | 30篇 |
1980年 | 25篇 |
1979年 | 25篇 |
1978年 | 14篇 |
1977年 | 13篇 |
1976年 | 24篇 |
1975年 | 25篇 |
1974年 | 16篇 |
1973年 | 17篇 |
1969年 | 14篇 |
1966年 | 12篇 |
排序方式: 共有1972条查询结果,搜索用时 31 毫秒
991.
Denis M. O'Mullane Clare E. Ketley Judith A. Cochran Helen P. Whelton W Peter Holbrook Cor van Loveren Barros Fernandes Liisa Seppä Thessaly Athanassouli 《Community dentistry and oral epidemiology》2004,32(S1):74-76
Abstract - An important challenge encountered in this multicentred project was the need to take account of the different cultural and legal differences between the seven sites when agreeing the protocol. Examples such as access to registers of births and subject consent dictated that there were some differences in the methods used in the different sites. The data presented showed that it was possible to train and calibrate a number of examiners in a standardized photographic method for recording enamel fluorosis. This method has a number of important advantages for the objective monitoring of enamel fluorosis over time. There were considerable differences between the seven sites in the formulations of the toothpaste used and in the pattern of their use. The results indicate that it is possible to agree and adopt a standardized method for measuring fluoride ingestion from toothpaste. The aesthetic impact of enamel fluorosis seemed low in the populations included in this project, but further work is required on this issue. 相似文献
992.
Pediatric amino acid products contain lower concentrations of methionine and require the addition of L-cysteine HCl just before infusion. Reports of a potential interaction between cysteine and copper, a routine addition to parenteral nutrition solutions, have appeared in the literature. This study serially evaluated cysteine/cystine and copper concentrations pre- and postfilter (0.22 microns) in two parenteral nutrition formulations prescribed for normal fluid (NF) or fluid-restricted (FR) pediatric patients. Solutions were infused via a peristaltic pump in vitro for 24 hours. Pre- and postfilter samples were obtained immediately after the infusion began (time 0) and at 1, 2, 3, 4, 8, 12, 16, 20, and 24 hours during the infusion. At 24 hours pre- and postfilter, cysteine/cystine were quantitated at 87.3% and 85% of the initial concentrations, respectively, for the NF solution and 92% and 91.5% for the FR solution. Pre- and postfilter copper was quantitated at 87.5% and 92.5% of the initial concentrations, respectively, for the NF solution and 88.2% and 95.2% for the FR solution. The 24 hour area under the curve for cysteine/cystine was 88.4% for the NF solution and 96.4% for the FR solution. For copper, the area under the curve for the NF solution was 99% and 96.7% for the FR solution. There was no visual evidence of incompatibility or precipitation. We conclude that copper-containing parenteral nutrition solutions with L-cysteine HCl added immediately before infusion are relatively stable after compounding and infusion over 24 hours. 相似文献
993.
Inflammation Research - 相似文献
994.
Evaluation and comparison of three mobilization methods for the collection of granulocytes 总被引:2,自引:0,他引:2
DB Jendiroba ; B Lichtiger ; E Anaissie ; V Reddy ; S O'Brien ; H Kantarjian ; EJ Freireich 《Transfusion》1998,38(8):722-728
BACKGROUND: Cancer chemotherapeutic regimens have become more potent and myeloablative. As a consequence, morbidity and mortality due to opportunistic infections have become a major challenge. The provision of adequate doses of viable granulocytes has thus become an important approach for circumventing the problem. A schedule for collecting therapeutic numbers of cells with minimal donor toxicity has yet to be established. STUDY DESIGN AND METHODS: An investigation of three mobilization schedules for the collection of granulocytes for transfusion–granulocyte-colony-stimulating factor (G-CSF) 5 micrograms per kg daily; G-CSF 5 micrograms per kg every other day, and prednisone 60 mg given orally (20 mg doses at 17 hours, 12 hours, and 2 hours before the collection). RESULTS: A total of 464 apheresis procedures involving 163 healthy donors were analyzed. Prednisone caused a small increase in the white cell (WBC) counts over the collection days, while G-CSF every other day and daily schedules improved WBC counts to 145 and 160 percent, respectively (p = 0.004). Similarly, administration of G-CSF daily and every other day mobilized higher yields of granulocytes over the collection days, compared to the prednisone schedule (170% and 180% vs. 105%; p = 0.02). CONCLUSION: Compared with prednisone, higher WBC yields were achieved by G-CSF stimulation; G-CSF given every other day is as effective as daily G-CSF administration for the recruitment of granulocytes, which makes the mobilization procedure more cost- effective. 相似文献
995.
996.
Normal renal artery spectral Doppler waveform: a closer look 总被引:4,自引:0,他引:4
997.
998.
Soiffer RJ; Gonin R; Murray C; Robertson MJ; Cochran K; Chartier S; Cameron C; Daley J; Levine H; Nadler LM 《Blood》1993,82(7):2216-2223
Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality following allogeneic bone marrow transplantation (BMT). Because GVHD is frequently refractory to treatment, the early identification of high-risk patients could have significant clinical value. To identify such patients, we examined early immunologic recovery in 136 patients with hematologic malignancies who received anti-T12 (CD6)-purged allogeneic bone marrow over a 9-year period. The majority of patients received marrow from HLA-matched sibling donors after ablation with cyclophosphamide and total body irradiation. No patients received any immune suppressive medications for GVHD prophylaxis. The fraction and absolute numbers of peripheral blood lymphocytes (PBL) expressing the CD3, CD4, CD8, and CD56 surface antigens were determined weekly by immunofluorescence analysis in patients beginning 8 to 14 days (week 2) after marrow infusion. Results in patients who did or did not subsequently develop GVHD post-BMT were compared. Within 2 weeks of marrow infusion, patients who developed grades 2-4 GVHD had significantly higher percentages and absolute numbers of CD8+ T cells and a lower fraction of CD56+ natural killer (NK) cells than individuals who remained free of GVHD. Thirty-five percent of patients whose PBL were greater than 25% CD8+ in the second posttransplant week developed GVHD, compared with only 3% of patients who had < or = 25% CD8+ cells (odds ratio 37.8; 95% confidence interval [CI] 4.1 to 397). A subgroup of patients at very high risk for GVHD could be identified based on the combined frequency of CD8+ T cells and NK cells in blood. Seventy-five percent of patients with greater than 25% CD8+ cells and < or = 45% CD56+ cells during week 2 post-BMT developed GVHD, compared with only 11% of the remaining patients (odds ratio 24.9; 95% CI, 5.3 to 117.0). None of the 23 patients with both less than 25% CD8+ cells and greater than 45% CD56+ cells in the second posttransplant week developed grades 2-4 GVHD. Our findings indicate that CD8+ T cells play an important role in the pathogenesis of GVHD in humans. Analysis of immune reconstitution early after BMT is useful in predicting the onset of GVHD and can help direct the implementation of treatment strategies before the appearance of clinical manifestations. Such interventions may decrease the morbidity and mortality associated with allogeneic BMT and ultimately improve overall survival. 相似文献
999.
1000.